Optimum Client’s Win Big at LSX European Lifestars Awards! Congratulations to Optimum’s clients – Asceneuron SA, Calliditas Therapeutics, DISCO Pharmaceuticals GmbH, Sofinnova Partners portfolio company Moon Surgical, Myricx Bio, and Novo Holdings, all of whom took home LSX European Lifestars awards! Plus, a special moment for Optimum’s Zoe Bolt who presented the award for Private […]
By Richard Staines, Optimum Strategic Communications It’s just two weeks until the Labour government announces its crucial first budget, which will set the tone for Keir Starmer’s term as prime minister. The government has been busy making its excuses ahead of the announcement. With talk of a £22 billion “Black Hole” in public finances blamed […]
· Increasing momentum as we expanded our portfolio of investments, built the team and fostered new partnerships · Three new portfolio company investments and two existing portfolio company financing extensions · First ever Novo Nordisk and Novo Holdings Partnering Day focusing on Cardio Metabolic disease Copenhagen, Denmark, 3 April 2024 – Novo Holdings Asia Investments team today publishes its […]
Optimum is a proud supporter of LSX. Every year it’s World Congress gathers the founders and CEOs of innovative start-ups through to publicly healthcare giants, and everyone in between.
COPENHAGEN, Denmark, 11 January 2022 – BioInnovation Institute (BII), a non-for profit Foundation known for incubating and advancing world-class life science research, today announces the award of a grant from the Bill & Melinda Gates Foundation to accelerate efforts to discover translational world-class research to identify new technologies and solutions that can improve the health of women […]
